menu
    • menu

    Company profile for Ablexis

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ablexis licenses the AlivaMab Mouse, a transgenic mouse that dramatically improves upon other antibody discovery platforms. A majority of the world’s top-15 pharmaceutical companies have licensed and use AlivaMab Mouse for antibody drug discovery at more than a dozen sites around the world. Founded in 2009, Ablexis brought together decades of knowledge and experience in building the AlivaMab Mouse, the best-in-class transgen...
    Ablexis licenses the AlivaMab Mouse, a transgenic mouse that dramatically improves upon other antibody discovery platforms. A majority of the world’s top-15 pharmaceutical companies have licensed and use AlivaMab Mouse for antibody drug discovery at more than a dozen sites around the world. Founded in 2009, Ablexis brought together decades of knowledge and experience in building the AlivaMab Mouse, the best-in-class transgenic platform for generating therapeutic antibody candidates with very high potency, specificity, solubility and reduced chance of immunogenicity.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AblexisUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    10581 Roselle Street, Suite 115, San Diego, CA 92121
    Telephone
    Telephone
    415.967.1220
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ablexis.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/ablexis
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ablexis Announces Availability of AlivaMab(R) Mouse-NGX
    Ablexis Announces Availability of AlivaMab(R) Mouse-NGX

    02 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-02/ablexis-announces-validation-and-availability-of-alivamab-r-mouse-ngx

    PHARMAWEB
    02 Sep 2025
    Share Share
    Ablexis Announces License Agreement with Adimab
    Ablexis Announces License Agreement with Adimab

    09 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230209005161/en/Ablexis-Announces-License-Agreement-with-Adimab

    BUSINESSWIRE
    09 Feb 2023
    Share Share
    Ablexis and AlivaMab Services Announce Expansion of Antibody Drug Discovery
    Ablexis and AlivaMab Services Announce Expansion of Antibody Drug Discovery

    14 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221115005487/en

    BUSINESSWIRE
    14 Nov 2022
    Share Share
    Ablexis & AlivaMab Discovery Services Announce Agreements with Almirall
    Ablexis & AlivaMab Discovery Services Announce Agreements with Almirall

    31 Jan 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220131005182/en

    BUSINESSWIRE
    31 Jan 2022
    Share Share
    Ablexis, AlivaMab Discovery Services,& Berkeley Lights Collab to Anti-SARS-CoV-2
    Ablexis, AlivaMab Discovery Services,& Berkeley Lights Collab to Anti-SARS-CoV-2

    22 Apr 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ablexis-alivamab-discovery-services-and-berkeley-lights-collaborate-to-identify-a-diverse-panel-of-anti-sars-cov-2-human-antibodies-301045039.html

    PR NEWSWIRE
    22 Apr 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search